| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.31 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.29 | 3e-07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.002 |